Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology
07 Jan 2021 //
PRNEWSWIRE
Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology
07 Jan 2021 //
BIOSPACE
Kleo Presents Preclinical Data on KPMW135, CD3 x CD20 Bispecific Rituximab
07 Dec 2020 //
GLOBENEWSWIRE
Kleo Pharmaceuticals to Present at “Bioscience Pipeline & Innovation
21 Sep 2020 //
BIOSPACE
Kleo Announces Orphan Drug Designation for KP1237 in Multiple Myeloma
08 Sep 2020 //
GLOBENEWS WIRE
Kleo Pharmaceuticals and Celularity Enter Research Collab Allogeneic NK Cell
21 May 2020 //
GLOBENEWSWIRE
Kleo Pharmaceuticals to Present Preclinical Data Potential of Kleo Asset KP1237
15 May 2020 //
GLOBENEWSWIRE